2013 Annual Results
Further strengthening of worldwide positions
Record operating margin
- Sales: 22.98 billion euros
- Operating profit: 3.875 billion euros, representing 16.9% of sales
- Net profit after non-controlling interests: +3.2%
- Net earnings per share*: +4.4% at 5.13 euros
- Dividend**: +8.7% at 2.50 euros
Lastly, profitability reached a record level in 2013, confirming the relevance of our business model.
In an economic context that is still marked by uncertainties, particularly on the monetary front, L’Oréal is confident in its ability to outperform the market once again in 2014, and to achieve another year of sales and profit growth.”
* Diluted net earnings per share, based on net profit excluding non-recurring items after non-controlling interests.
** Proposed at the Annual General Meeting of April 17, 2014.
A – 2013 sales
Sales by operational division and geographic zone
| 4th quarter 2013 | At December 31, 2013 | |||||
| Growth | Growth | |||||
| €m | Like-for-like | Reported | €m | Like-for-like | Reported | |
| By operational division | ||||||
| Professional Products | 726.1 | 3.3% | -2.1% | 2,973.8 | 2.1% | -1.0% |
| Consumer Products | 2,550.0 | 3.7% | -2.4% | 10,873.2 | 4.9% | 1.5% |
| L'Oréal Luxe | 1,600.2 | 8.4% | 5.5% | 5,865.2 | 6.8% | 5.3% |
| Active Cosmetics | 339.2 | 7.2% | 2.2% | 1,602.4 | 7.8% | 4.9% |
| Cosmetics total | 5,215.5 | 5.2% | 0.2% | 21,314.5 | 5.2% | 2.4% |
| By geographic zone | ||||||
| Western Europe | 1,803.3 | 1.6% | -0.1% | 7,483.4 | 1.9% | 1.1% |
| North America | 1,299.3 | 3.7% | 0.8% | 5,356.1 | 3.8% | 2.8% |
| New Markets, of which: | 2,112.9 | 9.4% | 0.2% | 8,475.0 | 9.4% | 3.3% |
| Asia-Pacific | 1,088.1 | 9.7% | -0.1% | 4,382.2 | 8.4% | 2.2% |
| Latin America | 472.5 | 10.8% | -0.5% | 1,894.5 | 11.5% | 3.7% |
| Eastern Europe(1) | 432.5 | 5.2% | -1.4% | 1,693.3 | 8.2% | 4.2% |
| Africa, Middle East(1) | 119.8 | 18.0% | 11.7% | 505.1 | 14.3% | 9.0% |
| Cosmetics total | 5,215.5 | 5.2% | 0.2% | 21,314.5 | 5.2% | 2.4% |
| The Body Shop | 287.0 | 2.9% | -1.1% | 835.8 | 1.2% | -2.3% |
| Dermatology(2) | 260.9 | 12.9% | 10.4% | 826.3 | 3.9% | 3.9% |
| Group total | 5,763.4 | 5.4% | 0.6% | 22,976.6 | 5.0% | 2.3% |
(1) As of July 1st, 2013, Turkey and Israel, which were previously included in the Africa, Middle East zone, were transferred to the Eastern Europe zone. All figures for earlier periods have been restated to allow for this change.
(2) Group share, i.e. 50%.
1) Cosmetics sales
PROFESSIONAL PRODUCTS
The Professional Products Division recorded growth of +2.1% like-for-like and -1.0% based on reported figures in a channel that was still affected by declining salon visits in the mature markets, but remains dynamic in the New Markets.
- In the very buoyant luxury haircare segment, Kérastase, the Division's number one brand in terms of growth contribution, had a very good year, thanks to "Couture Styling" and Initialiste.
Haircare is continuing to grow strongly, thanks to the success of the hair oils and the launch of Biolage Advanced by Matrix.
Hair colourants have been driven by Hairchalk from L'Oréal Professionnel, the first-ever make-up for hair, and the ramp-up of ODS 2 technology.
Essie continues to grow; its recent launch, Essie Gel, is a resounding success. - In geographic terms, the Division's brands are maintaining their positions in mature markets which remain lacklustre. The Division is growing strongly across all the New Markets excluding Japan. Brazil, Russia and India were amongst the largest contributors to growth.
CONSUMER PRODUCTS
The Consumer Products Division posted growth of +4.9% like-for-like and +1.5% based on reported figures. The Division is outperforming the global market and winning market share.
- The trends of all the Division's brands were favourable, and all grew faster than the market. Growth at L'Oréal Paris is accelerating, and the brand is strengthening its worldwide leadership, thanks to a very strong performance in haircare. The brand is also growing strongly in facial skincare with Age Perfect Cell Renew and has chalked up successes in hair colourants with Préférence Wild Ombrés and in make-up with Butterfly mascara.
Garnier recorded double-digit growth in hair colourants, thanks to Olia. The brand's growth in facial skincare is continuing with the BB creams.
Maybelline posted strong growth in the lipstick category with the launch of Rouge Elixir and in more accessible categories such as nail varnishes and eyeliners.
SoftSheen.Carson is making progress thanks to the launch of Amla Legend.
- The Division had a very good year in Western Europe, where it continues to improve its leadership position. In North America, business was affected by the market slowdown and the adjustment in distributors' inventories, but sell-out increased two and a half times faster than the market. Brazil, India, Indonesia, Turkey and the Gulf states all performed very well.
L'OREAL LUXE
After a strong end to the year, L'Oréal Luxe grew by +6.8% like-for-like and +5.3% based on reported figures. The Division is significantly outperforming selective market growth.
- Lancôme delivered another solid year in fragrances with La Vie est Belle, which established itself as a top seller, and in skincare its sales were highly dynamic, with the innovative Advanced Génifique and Dreamtone. Asserting its status as a major luxury brand, Giorgio Armani posted a very strong year thanks to the success of its women's fragrance Sì, already in the European top 5, and to its Armani Beauty line, which made a real breakthrough this year. Yves Saint Laurent is extending its reach in Asia, particularly in China, and has a global success on its hands with Vernis à Lèvres Rebel Nudes. Kiehl's, Clarisonic and Urban Decay are recording very strong growth on all continents. Their latest launches - respectively Super Multicorrective Cream, Pedi Sonic Foot Transformation System and the Naked 3 make-up palette - have all been big successes. As for the designer fragrance brands, Ralph Lauren is proving extremely successful in North America and Latin America with the launch of Polo Red. Viktor&Rolf continued its strong growth.
- Over the full year, L'Oréal Luxe outperformed the market in all its major zones, and in Travel Retail.
ACTIVE COSMETICS
In 2013, the Division recorded strong sales growth of +7.8% like-for-like and +4.9% based on reported figures, clearly strengthening its position as the world leader in the dermocosmetics market.
- The Vichy brand is going from strength to strength in skincare with the continuing development of its Idealia franchise (BB Cream, Life Serum) and the launch of Néovadiol Magistral. In the haircare segment, Dercos Neogenic, a treatment which redensifies the hair, is proving successful.
La Roche-Posay posted another year of double-digit growth, with a series of successes in all regions of the world. The brand's growth is being driven by the solid roll-out of benchmark franchises prescribed by dermatologists, such as Effaclar and Lipikar, and the more recent launches of Redermic R, Substiane Serum and Iso Urea MD.
SkinCeuticals is achieving good performances, and is continuing its rapid expansion. The brand is launching a bodycare range to be used in association with aesthetic procedures, and is thus beginning the conquest of a new segment.
- Across the regions, the Division's trends remain favourable in Western Europe, growing twice as fast as the market. The New Markets are proving highly dynamic, particularly in Brazil and China.
Multi-division summary by geographic zone
WESTERN EUROPE
In a context that remained difficult, particularly in Southern Europe, growth came out at +1.9% like-for-like and +1.1% based on reported figures.
All the Divisions are making market share gains, particularly in France, Germany and the United Kingdom. L'Oréal Luxe sales are being driven by Lancôme, Giorgio Armani and Kiehl's, and Consumer Products Division sales by Garnier and L'Oréal Paris. The success of La Roche-Posay and Vichy is enabling the Active Cosmetics Division to reinforce its number one position.
NORTH AMERICA
Sales advanced by +3.8% like-for-like and by +2.8% based on reported figures. In a market that was less dynamic than in 2012, the Group made market share gains. The Consumer Products Division consolidated its market leader position thanks to strong growth at L'Oréal Paris with the success of Advanced Hair Care. L'Oréal Luxe outperformed its market, thanks in particular to the very good results of its American brands Urban Decay, Clarisonic and Kiehl's. In the Professional Products Division, the launches of Diamond Oil by Redken and Essie Gel are very promising.
NEW MARKETS
- Asia-Pacific: L'Oréal recorded annual growth of +8.4% like-for-like and +2.2% based on reported figures. Excluding Japan, like-for-like growth reached +9.5%. Except for South Korea, the markets remain dynamic, despite slower growth in China and India.
Market share is increasing in this zone, reflecting in particular the good performance of L'Oréal Paris in China in the facial skincare and haircare categories, and of Garnier in the same categories in South-East Asia. L'Oréal is also performing very well in luxury products, thanks to the strong growth of Lancôme and Kiehl's and the roll-out of Yves Saint Laurent and Clarisonic.
- Latin America: L'Oréal recorded growth of +11.5% like-for-like and +3.7% based on reported figures. The Consumer Products Division is driven by Bi-O deodorants by Garnier, Maybelline make-up, the success of the BB creams at L'Oréal Paris and haircare, with the renewal of Elvive and Fructis. The Active Cosmetics Division very clearly outperformed its market. In Brazil, all the Divisions made market share gains.
- Eastern Europe: Sales increased by +8.2% like-for-like and +4.2% based on reported figures, significantly outperforming the market trend. The Consumer Products Division is winning market share once again, thanks to Olia hair colourants by Garnier and Dermo-Expertise skincare with Revitalift Laser. The Professional Products Division and L'Oréal Luxe made market share gains. The Active Cosmetics Division is growing faster than the market in Russia, thanks to the dynamic sales of La Roche-Posay.
- Africa, Middle East: Sales increased by +14.3% like-for-like and +9.0% based on reported figures, reflecting the good performances of the new subsidiary in Saudi Arabia, strong growth in the Gulf states, Egypt and Pakistan and the recent acquisition of Interbeauty in Kenya. All the Divisions recorded double-digit growth in 2013. Performances were particularly encouraging for Lancôme, Giorgio Armani, Kérastase, Garnier, Maybelline and Vichy, all of which posted growth significantly higher than the market.
2) The Body Shop sales
The Body Shop recorded +1.2% like-for-like sales and -2.3% based on reported figures. The strategic body, skincare and makeup categories grew driven by iconic ranges and innovations such as Honeymania bodycare with organic Community Fair Trade honey from Ethiopia.
The Body Shop secured a good Christmas trading around its "Give Joy" programme.
The Body Shop multi-channel strategy delivered sustained growth in ecommerce, particularly in the United Kingdom and in the United States.
Geographically, the main markets which contributed to the brand's development were South Asia and Northern Europe.
3) Galderma sales
Galderma sales increased by +3.9% like-for-like and +3.9% based on reported figures, confirming the success of its innovative medical solutions in its three fields of activity.
In the prescription drug market, where competition from generics is having an impact on the performance of Galderma in Europe and the United States, Epiduo posted strong growth, confirming its position as the world's number one prescription product in the topical acne treatment market. Mirvaso, a major innovation in the treatment of rosacea-associated erythema, was successfully launched in the United States. The portfolio of self-medication products continues to grow strongly, thanks in particular to Cetaphil and Loceryl. The good performances of the aesthetic and corrective medical solutions are being driven by the strong growth of Azzalure and the growth of Restylane.
The particularly solid growth recorded in the New Markets, notably in Asia-Pacific, Russia and Latin America, is bolstering the global expansion of Galderma.
B - Important events during the period 10/01/13 - 12/31/13
- On October 15, L'Oréal announced the acquisition by The Body Shop of a majority stake in Emporio Body Store in Brazil, with the option of increasing its shareholding to 80% by 2019. Following approval by the Brazilian anti-trust authority CADE, the acquisition was completed on December 12.
- On October 17, 2013, L'Oréal announced that it had been granted exclusive negotiation rights by Shiseido for the acquisition of the Decléor and Carita brands.
- On November 19, 2013, Beauté Créateurs, a subsidiary that distributes brands specific to the mail order business, announced its intention to cease its mail order activity during the first half of 2014.
- On November 21, 2013, L'Oréal announced that it was creating a Group Travel Retail Division encompassing all the brands sold in the Travel Retail channel, whose growth is particularly dynamic.
- On November 29, 2013, the Board of Directors meeting chaired by Mr Jean-Paul Agon decided to buy back L'Oréal shares for an amount of 500 million euros between November 30 and the end of the first quarter of 2014.
C - Results 2013
Audited financial statements, certification in progress.
1) Operating profitability at 16.9% of sales
Consolidated profit and loss account: from sales to operating profit.
| 2012 | 2013 | |||
| €m | % sales | €m | % sales | |
| Sales | 22,462.7 | 100.0% | 22,976.6 | 100.0% |
| Cost of sales | -6,587.7 | 29.3% | -6,601.8 | 28.7% |
| Gross profit | 15,875.0 | 70.7% | 16,374.8 | 71.3% |
| Research and development expenses | -790.5 | 3.5% | -857.0 | 3.7% |
| Advertising and promotion expenses | -6,776.3 | 30.2% | -6,886.2 | 30.0% |
| Selling, general and administrative expenses | -4,610.9 | 20.5% | -4,756.8 | 20.7% |
| Operating profit | 3,697.3 | 16.5% | 3,874.8 | 16.9% |
Gross profit, at 16,374 million euros, came out at 71.3% of sales, compared with 70.7% in 2012, that is an improvement of 60 basis points.
This improved figure reflects on the one hand the positive effects of improvements in the production costs of products and in the product mix effect, as well as currency fluctuations, and on the other hand, the negative impact of the consolidation of the American companies Urban Decay and Emiliani.
Research expenses increased strongly at 8.4% and thus increased as a percentage of sales from 3.5% to 3.7%.
Advertising and promotion expenses came out at 30% of sales, almost identical to the 2012 level.
Excluding acquisitions, expenses remained stable as a percentage of sales.
Selling, general and administrative expenses, at 20.7% of sales, came out slightly higher, by 20 basis points, than in 2012.
Overall, operating profit, at 3,875 million euros, increased by 4.8% at 16.9% of sales. On a constant exchange rate basis, operating growth would have been +7.8%.
2) Operating profit by branch and division
| 2012 | 2013 | |||
| €m | % sales | €m | % sales | |
| By operational division | ||||
| Professional Products | 615.2 | 20.5% | 609.5 | 20.5% |
| Consumer Products | 2,050.8 | 19.1% | 2,166.7 | 19.9% |
| L'Oréal Luxe | 1,077.0 | 19.3% | 1,174.2 | 20.0% |
| Active Cosmetics | 311.2 | 20.4% | 340.2 | 21.2% |
| Cosmetics divisions total | 4,054.3 | 19.5% | 4,290.6 | 20.1% |
| Non-allocated* | -577.2 | -2.8% | -604.5 | -2.8% |
| Cosmetics branch total | 3,477.1 | 16.7% | 3,686.1 | 17.3% |
| The Body Shop | 77.5 | 9.1% | 71.9 | 8.6% |
| Dermatology branch** | 142.6 | 17.9% | 116.8 | 14.1% |
| Group | 3,697.3 | 16.5% | 3,874.8 | 16.9% |
* Non-allocated = Central Group expenses, fundamental research expenses, stock options and free grant of shares expenses and miscellaneous items. As a % of cosmetics sales.
** Group share, i.e. 50%.
The profitability of the Professional Products Division at 20.5% is in line with previous years.
The profitability of the Consumer Products Division, at 19.9%, improved by 80 basis points.
The profitability of L'Oréal Luxe grew by 70 basis points.
Active Cosmetics once again improved its profitability, which amounted to 21.2%.
The profitability of The Body Shop declined by 50 basis points in 2013 to 8.6%.
Finally, the profitability of Galderma, at 14.1%, reflects the impact of a difficult year in the United States.
3) Profitability by geographic zone
| 2012 | 2013 | |||
| €m | % sales | €m | % sales | |
| Operating profit | ||||
| Western Europe | 1,576.2 | 21.3% | 1,658.6 | 22.2% |
| North America | 959.7 | 18.4% | 1,003.1 | 18.7% |
| New Markets | 1,518.4 | 18.5% | 1,628.9 | 19.2% |
| Cosmetics zones total* | 4,054.3 | 19.5% | 4,290.6 | 20.1% |
* Before non-allocated.
Profitability in Western Europe improved by 90 basis points at 22.2%.
Profitability in North America increased by 30 basis points at 18.7%.
Profitability in the New Markets increased by 70 basis points at 19.2%.
4) Net earnings per share**: 5.13 euros
Consolidated profit and loss accounts: from operating profit to net profit excluding non-recurring items.
| €m | 2012 | 2013 | % change |
| Operating profit | 3,697.3 | 3,874.8 | +4.8% |
| Financial revenues and expenses excluding dividends received | -11.0 | -42.7 | |
| Sanofi dividends | 313.4 | 327.5 | |
| Profit before tax excluding non-recurring items | 3,999.7 | 4,159.6 | +4.0% |
| Income tax excluding non-recurring items | -1,025.3 | -1,038.9 | |
| Non-controlling interests | -2.7 | -3.2 | |
| Net profit excluding non-recurring items after non-controlling interests* | 2,971.7 | 3,117.5 | |
| Net EPS** (€) | 4.91 | 5.13 | +4.4% |
| Net profit after non-controlling interests | 2,867.7 | 2,958.2 | +3.2% |
| Diluted net EPS after non-controlling interests (€) | 4.74 | 4.87 | |
| Diluted average number of shares | 605,305,458 | 608,001,407 |
* Net profit excluding non-recurring items after non-controlling interests does not include impairment of assets, restructuring costs, tax effects or non-controlling interests.
** Diluted net earnings per share excluding non-recurring items after non-controlling interests.
Total financial costs amounted to 42 million euros.
Dividends from Sanofi amounted to 327 million euros.
Income tax excluding non-recurring items amounted to 1,038 million euros, representing a rate of 25%, slightly below the 2012 rate of 25.6%.
Net profit excluding non-recurring items after non-controlling interests amounted to 3,117 million euros.
Net earnings per share, at 5.13 euros, increased by 4.4%.
After allowing for non-recurring items, representing in 2013 a charge, net of tax, of 159 million euros, net profit after non-controlling interests amounted to 2,958 million euros, an increase of 3.2%.
5) Cash flow statement, Balance sheet and Net financial situation
Gross cash flow amounted to 3,906 million euros, an increase of 6.7%.
The working capital requirement increased, in 2013, by 155 million euros.
Inventories increased slightly as a percentage of sales, rising from 9.1% at end-2012 to 9.4% at end-2013. Trade accounts receivable declined slightly, from 14.3% of sales at end-2012 to 14.2% at end-2013.
Investments, at 1,060 million euros, amounted to 4.6% of sales, slightly up on 2012, when they amounted to 4.3% of sales.
As a result, operating cash flow, at 2,689 million euros, increased by 4.4%.
After dividend payment and acquisitions (primarily Vogue, InterConsumer Products, Emporio Body Store and Spirig), the Group recorded, at December 31, 2013, a net cash surplus of 2,215 million euros, compared with 1,575 million euros at end-2012.
The balance sheet is extremely solid. The reinforcement of shareholders' equity compared with end-2012 is mainly the result of the profit allocated to reserves and the increase in value of the Sanofi shares, valued at market price.
6) Proposed dividend at the Annual General Meeting of April 17, 2014
The Board of Directors has decided to propose that the Shareholders' Annual General Meeting of April 17, 2014 should approve a dividend of 2.50 euros per share, an increase of 8.7% compared with the dividend paid in 2013. The dividend will be paid on May 5, 2014 (ex-dividend date April 29, 2014 at 0:00 a.m., Paris time).
7) Share capital
As of January 31, 2014, the capital of the company is formed by 606,059,384 shares, each with one voting right.
"This news release does not constitute an offer to sell, or a solicitation of an offer to buy L'Oréal shares. If you wish to obtain more comprehensive information about L'Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers, also available in English on our Internet site www.loreal-finance.com.
This news release may contain some forward-looking statements. Although the Company considers that these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nature subject to risks and uncertainties which could cause actual results to differ materially from those indicated or projected in these statements."
This is a free translation into English of the news release of the Annual Results 2013 issued in the French language and is provided solely for the convenience of English speaking readers. In case of discrepancy, the French version prevails.
Contacts at L'Oréal
Individual shareholders and market authorities
Mr Jean Régis CAROF
Tel.: +33 1 47 56 83 02
[email protected]
Financial analysts and institutional investors
Mrs Françoise LAUVIN
Tel.: +33 1 47 56 86 82
[email protected]
Journalists
Mrs Stephanie CARSON-PARKER
Tel.: +33 1 47 56 76 71
[email protected]
Switchboard
Tel.: +33 1 47 56 70 00
For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, and the Internet site for shareholders and investors, www.loreal-finance.com, or call +33 1 40 14 80 50.
Practical Information:
A Press Briefing for journalists with Jean-Paul Agon will be held at 8:00 am local time at L’Oréal Headquarters.
D – Appendices
Appendix 1: L'Oréal group sales 2012/2013 (€ millions)
| 2012 | 2013 | |
| First quarter: | ||
| Cosmetics | 5,309 | 5,593 |
| The Body Shop | 180 | 182 |
| Dermatology | 154 | 157 |
| First quarter total | 5,643 | 5,932 |
| Second quarter: | ||
| Cosmetics | 5,162 | 5,396 |
| The Body Shop | 194 | 187 |
| Dermatology | 215 | 224 |
| Second quarter total | 5,570 | 5,806 |
| First half: | ||
| Cosmetics | 10,471 | 10,989 |
| The Body Shop | 374 | 369 |
| Dermatology | 368 | 381 |
| First half total | 11,213 | 11,738 |
| Third quarter: | ||
| Cosmetics | 5,137 | 5,110 |
| The Body Shop | 191 | 180 |
| Dermatology | 191 | 185 |
| Third quarter total | 5,519 | 5,475 |
| Nine months: | ||
| Cosmetics | 15,608 | 16,099 |
| The Body Shop | 565 | 549 |
| Dermatology | 559 | 565 |
| Nine months total | 16,732 | 17,213 |
| Fourth quarter: | ||
| Cosmetics | 5,204 | 5,216 |
| The Body Shop | 290 | 287 |
| Dermatology | 236 | 261 |
| Fourth quarter total | 5,730 | 5,763 |
| Full year: | ||
| Cosmetics | 20,812 | 21,315 |
| The Body Shop | 855 | 836 |
| Dermatology | 796 | 826 |
| Full year total | 22,463 | 22,977 |
